Cohen & Steers Inc. (CNS)
NYSE: CNS
· Real-Time Price · USD
76.60
-1.36 (-1.74%)
At close: Aug 14, 2025, 3:59 PM
76.63
0.04%
After-hours: Aug 14, 2025, 05:54 PM EDT
-1.74% (1D)
| Bid | 76.63 |
| Market Cap | 3.91B |
| Revenue (ttm) | 559.32M |
| Net Income (ttm) | 162.12M |
| EPS (ttm) | 3.15 |
| PE Ratio (ttm) | 24.32 |
| Forward PE | 21.51 |
| Analyst | Hold |
| Ask | 77.39 |
| Volume | 116,212 |
| Avg. Volume (20D) | 205,401 |
| Open | 76.96 |
| Previous Close | 77.96 |
| Day's Range | 76.13 - 77.00 |
| 52-Week Range | 68.99 - 110.67 |
| Beta | 1.35 |
Analyst Forecast
According to 0 analyst ratings, the average rating for CNS stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Cohen & Steers Inc. is scheduled to release its earnings on
Oct 15, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
4 months ago
+9.62%
Shares of capital market companies are trading hig...
Unlock content with
Pro Subscription
4 months ago
+2.6%
Shares of financial stocks are trading higher amid overall market strength on reports of potentially narrowed or targeted tariffs, which may be easing investor concerns.
1 month ago · accessnewswire.com
CNS Pharmaceuticals Participates in Virtual Investor CEO Connect SegmentHOUSTON, TX / ACCESS Newswire / July 9, 2025 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for pri...
